Research output per year
Research output per year
Fingerprint
Dive into the research topics where Luca Richeldi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Advances with pharmacotherapy for the treatment of interstitial lung disease
Comes, A., Sgalla, G., Perrotta, A. & Richeldi, L., 2021, (Accepted/In press) In: Expert Opinion on Pharmacotherapy.Research output: Contribution to journal › Article › peer-review
-
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19
The Gemelli against Covid Group, Dec 2021, In: Scientific Reports. 11, 1, 21136.Research output: Contribution to journal › Article › peer-review
Open Access -
A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement
Blasi, F., Di Pasquale, M., Gramegna, A., Viale, P., Iacobello, C., Gori, A., Tumbarello, M., Esposito, S., Richeldi, L. & Bassetti, M., Dec 2021, In: Respiratory Medicine. 190, 106674.Research output: Contribution to journal › Article › peer-review
Open Access -
An updated safety review of the drug treatments for idiopathic pulmonary fibrosis
Sgalla, G., Comes, A. & Richeldi, L., 2021, In: Expert Opinion on Drug Safety. 20, 9, p. 1035-1048 14 p.Research output: Contribution to journal › Article › peer-review
-
ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments
ARIA Italia, Oct 2021, In: World Allergy Organ. J.. 14, 10, p. 100592Research output: Contribution to journal › Article › peer-review